Cargando…
Normalisation of brain spectroscopy findings in Niemann–Pick disease type C patients treated with miglustat
Niemann–Pick disease type C (NP-C) is a fatal progressive neurolipidosis involving neuronal storage of cholesterol and gangliosides. Miglustat, an inhibitor of glycosphingolipid synthesis, has been approved to treat neurological manifestations in adults and children with NP-C. This open-label observ...
Autores principales: | Sedel, Frédéric, Chabrol, Brigitte, Audoin, Bertrand, Kaphan, Elsa, Tranchant, Christine, Burzykowski, Tomasz, Tourbah, Ayman, Vanier, Marie T., Galanaud, Damien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859844/ https://www.ncbi.nlm.nih.gov/pubmed/26984608 http://dx.doi.org/10.1007/s00415-016-8051-1 |
Ejemplares similares
-
Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C
por: Héron, Bénédicte, et al.
Publicado: (2012) -
Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect
por: Nadjar, Yann, et al.
Publicado: (2018) -
Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study
por: Freihuber, Cécile, et al.
Publicado: (2023) -
Miglustat in Niemann-Pick disease type C patients: a review
por: Pineda, Mercè, et al.
Publicado: (2018) -
Evolution of structural neuroimaging biomarkers in a series of adult patients with Niemann-Pick type C under treatment
por: Masingue, Marion, et al.
Publicado: (2017)